K 777

Drug Profile

K 777

Alternative Names: APC-3316; CRA-3316; K-777

Latest Information Update: 28 Jul 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Celera Genomics Group; University of California at San Francisco
  • Developer Institute for OneWorld Health; National Institutes of Health (USA)
  • Class Amides; Antiprotozoals; Piperazines; Small molecules; Sulfones
  • Mechanism of Action Cruzain inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Chagas disease

Most Recent Events

  • 03 Sep 2005 This compound is still in active development
  • 27 Feb 2002 Preclinical trials in Chagas' disease in USA (PO,Tablet)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top